89zr-ny008
PeptideexperimentalImaging agent
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 25, 2022 (NCT05655676)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 89-zirconium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05691855 | Early Phase 1 (Phase 1) | Jun 1, 2022 | Jiangnan University |
| NCT05655676 | Early Phase 1 (Phase 1) | May 25, 2022 | Jiangnan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangnan University | Academic/Hospital | 2 | 2 | 1 | 2022 |
1 organizations
Page 1 / 1